cronassial

09/01/1993 - "Electrophysiological study on diabetic neuropathy treated with Cronassial."
07/01/1986 - "Cronassial, a combination of four different cerebral gangliosides, was administered intramuscularly (40 mg daily) in a double-blind controlled study of 28 patients with moderate to severe diabetic neuropathy. "
01/01/1984 - "Cronassial, a combination of four different cerebral gangliosides, was evaluated in a six month double blind controlled study involving 25 patients with symptomatic diabetic neuropathy (12 receiving Cronassial, 13 receiving placebo). "
01/01/1988 - "Since a bovine brain ganglioside mixture (Cronassial) has been extensively studied for its effect on peripheral diabetic neuropathy, a group of diabetic mice was treated throughout the sixth month with this drug (10 mg/kg/day i.p.). "
11/01/1987 - "The efficacy of daily intramuscular injection of mixed gangliosides (Cronassial) for highly symptomatic diabetic neuropathy was investigated in a randomized double-blind trial. "

01/01/2023 - "Cronassial Ameliorates Autoimmune Encephalomyelitis by Inhibiting Lipid Oxidation and Carbonyl Stress in the Brain and Spinal Cord of Rats."
01/01/2023 - "Consequently, the data obtained highlight the neuroprotective and antioxidant effects of Cronassial when administered to animals with autoimmune encephalomyelitis."

09/01/1990 - "[A trial of cronassial use in late postpoliomyelitis syndrome]."
09/01/1990 - "The results are presented of treatment with gangliosides (Cronassial) in 5 patients with late postpoliomyelitis syndrome. "

01/01/1992 - "The study presents the evaluation of treatment by Cronassial of 26 patients including 16 with post-inflammatory optic atrophy, 4 with optic neuritis and 6 multiple sclerosis patients with optic neuropathy. "

01/01/1992 - "The study presents the evaluation of treatment by Cronassial of 26 patients including 16 with post-inflammatory optic atrophy, 4 with optic neuritis and 6 multiple sclerosis patients with optic neuropathy. "